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Abstract
The complete genome sequence of the first equine coronavirus (ECoV) isolate, NC99 strain was accomplished by directly sequencing 11
overlapping fragments which were RT–PCR amplified from viral RNA. The ECoV genome is 30,992 nucleotides in length, excluding the polyA tail.
Analysis of the sequence identified 11 open reading frames which encode two replicase polyproteins, five structural proteins (hemagglutinin esterase,
spike, envelope, membrane, and nucleocapsid) and four accessory proteins (NS2, p4.7, p12.7, and I). The two replicase polyproteins are predicted to
be proteolytically processed by three virus-encoded proteases into 16 non-structural proteins (nsp1–16). The ECoV nsp3 protein had considerable
amino acid deletions and insertions compared to the nsp3 proteins of bovine coronavirus, human coronavirus OC43, and porcine hemagglutinating
encephalomyelitis virus, three group 2 coronaviruses phylogenetically most closely related to ECoV. The structure of subgenomic mRNAs was
analyzed by Northern blot analysis and sequencing of the leader–body junction in each sg mRNA.
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Coronaviruses are mainly associated with respiratory and
gastrointestinal disease in humans (Drosten et al., 2003; Holmes,
2001; Ksiazek et al., 2003; Peiris et al., 2003; van der Hoek et al.,
2004; Woo et al., 2005) and respiratory, enteric, neurological, or
hepatic disease in animals (Holmes, 2001). Coronaviruses have
also been isolated from bats, poultry and other birds (Cavanagh,
2005; Chu et al., 2006; Poon et al., 2005; Ren et al., 2006). On
the basis of antigenic and genetic analyses, coronaviruses are
divided into three groups (Gonzalez et al., 2003; Gorbalenya et
al., 2004; Snijder et al., 2003). Group 1 viruses include human
coronaviruses 229E (HCoV-229E) and NL63 (HCoV-NL63),
canine coronavirus (CCoV), feline coronavirus (FCoV), porcine
transmissible gastroenteritis virus (TGEV), porcine epidemic
diarrhea virus (PEDV), and bat coronavirus. Group 2 viruses are
subdivided into group 2a which includes murine hepatitis virus⁎ Corresponding author. Fax: +1 859 257 8542.
E-mail address: ubalasuriya@uky.edu (U.B.R. Balasuriya).
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doi:10.1016/j.virol.2007.06.035(MHV), human coronaviruses OC43 (HCoV-OC43) and HKU1
(HCoV-HKU1), bovine coronavirus (BCoV), porcine hemag-
glutinating encephalomyelitis virus (PHEV), and rat coronavirus
(RCov), and group 2b which includes SARS-coronavirus
(SARS-CoV). Group 3 viruses include avian viruses, such as
avian infectious bronchitis virus (IBV), and turkey coronavirus
(TCoV).
Members of the family Coronaviridae are enveloped,
positive-stranded RNA viruses with exceptionally large, poly-
cistronic genomes (27–32 kb). The 5′-proximal two-thirds of the
genome comprises two open reading frames (ORFs), ORF1a and
ORF1b, which encode the replicase polyproteins (pp) 1a and
pp1ab (Ziebuhr, 2005). Expression of the pp1ab requires a −1
ribosomal frameshift during translation of the genomic RNA
(Brierley et al., 1987). The two replicase polyproteins are pro-
cessed extensively by two or three viral proteases encoded by
ORF1a to generate up to 16 end-products termed nonstructural
proteins (nsp) 1 to 16 and multiple processing intermediates
(Ziebuhr, 2005; Ziebuhr et al., 2000). The N-proximal region of
the polyproteins is processed by one or two papain-like proteases
(PLpro), whereas the central and C-proximal region is processed
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2005; Ziebuhr et al., 2000). The 3′-proximal one-third of the
genome encodes structural proteins and various accessory
proteins. Genes encoding the four structural proteins present in
all coronaviruses occur in the 5′ to 3′ order as spike (S), envelope
(E), membrane (M), and nucleocapsid (N) proteins (Brian and
Baric, 2005; Lai et al., 2006). Some coronaviruses contain an
additional structural protein, the hemagglutinin–esterase (HE)
protein which is located upstream of the S protein gene (Lai et
al., 2006). In contrast to the replicase proteins which are directly
translated from the genomic RNA, coronavirus structural and
accessory proteins are expressed from a nested set of 3′ co-
terminal subgenomic (sg) mRNAs that also possess a common
5′ leader sequence derived from the 5′ end of the genome
(Pasternak et al., 2006; Sawicki et al., 2007). The common 5′
leader is fused to the 3′ body segments through amechanism that
is presumed to involve discontinuous minus strand RNA
synthesis to produce subgenome-length templates for subge-
nomic mRNA synthesis, with the transcription regulatory se-
quence (TRS) elements determining the fusion sites of leader
and body segments (see recent review of Pasternak et al., 2006;
Sawicki et al., 2007 for details).
Equine coronavirus (ECoV) was first isolated from feces of a
diarrheic foal in 1999 (ECoV-NC99) in North Carolina, USA
(Guy et al., 2000). Little is known about ECoV and its clinical
significance. Molecular characterization of ECoV and develop-
ment of diagnostic and prophylactic reagents necessitate
sequencing of ECoV. In this study, we determined the full-
length nucleotide sequence of the ECoV-NC99 strain of equine
coronavirus. The viral genome and proteome were analyzed and
the predicted features of ECoV nonstructural, structural, and
accessory proteins were compared to those of other corona-
viruses. Synthesis of sg mRNAs in ECoV-infected cells was
analyzed by Northern blotting. The leader–body junction
sequence in each sg mRNA was determined and the exact
position of TRS used for synthesis of each sg mRNA was
mapped on the genome. The evolutionary relationship between
ECoV and other phylogenetically closely related group 2a
coronaviruses was explored.
Results and discussion
ECoV genome sequence analysis
We report here the full-length genomic sequence of the first
ECoV isolate, the NC99 strain, and this is also the first reported
complete genome sequence of ECoV. The nucleotide sequence
was determined by directly sequencing 11 overlapping cDNA
fragments which were RT–PCR amplified from viral RNA. The
ECoV-NC99 genome comprises 30,992 nucleotides (nt),
excluding the 3′ poly (A) tail, and has a GC content of 37.2%.
The nucleotide sequence data have been deposited in GenBank
under accession number EF446615.
Both 5′ and 3′ ends of the ECoV genome contain short
untranslated regions (UTR). The 5′ UTR comprises 209 nt (1–
209) and includes a potential short internal ORF of 8 codons (nt
99–125). Four stem–loop structures (I, II, III, and IV) wereidentified in the 5′UTR and a short stretch of nucleotides that are
part of the ORF1a (see Supplementary Fig. S1). The bulged
stem–loop III (96–115) and IV (189–208) closely resemble the
stem–loop III and IV that have been identified as replication
signaling elements in bovine coronavirus and other group 2
coronaviruses (Raman and Brian, 2005; Raman et al., 2003; Wu
et al., 2003). The 3′UTR of the ECoV genome comprises 289 nt
(30,704–30,992) and contains a putative bulged stem–loop
structure (nt 30,703–30,770) and a putative pseudoknot struc-
ture (30,766–30,819) (see Supplementary Fig. S2). Similar
putative bulged stem–loop structure and pseudoknot structure
have been identified in murine hepatitis virus and other group 2
coronaviruses; these have been shown to be essential for viral
replication (Goebel et al., 2004a,b; Hsue and Masters, 1997;
Hsue et al., 2000; Williams et al., 1999).
Analysis of the ECoV-NC99 genome reveals 11 potential
ORFs (1a, 1b, 2–8, 9a and 9b) as shown in Fig. 1 and Table 1.
The ORFs 1a and 1b encode the replicase polyproteins pp1a
and pp1ab. The ORFs 2–8, 9a and 9b encode structural and
accessory proteins NS2, HE, S, p4.7, p12.7, E, M, N, and I,
respectively.
The replicase ORF1a (nt 210–13,499) and replicase ORF1b
(13,478–21,595) occupy 21.4 kb (69%) of the ECoV-NC99
genome. The translation of ORF1a generates a precursor pp1a of
4,429 amino acids. Similar to other coronaviruses, translation of
ORF1b involves a −1 ribosomal frameshift, generating a 7128-
amino acid pp1ab. The ribosomal frameshift is assumed to be
directed by two signals in the ORF1a/1b overlapping region: a
slippery sequence 5′UUUAAAC3′ (nt 13,472–13,478) and a
predicted downstream RNA pseudoknot structure (nt 13,484–
13,559) (see Supplementary Fig. S3). The pp1a and pp1ab
proteins are predicted to be proteolytically processed by viral-
encoded proteases into 16 non-structural proteins (nsp1–16,
Table 2) required for viral replication and transcription. By
comparison to other coronaviruses, a number of putative
functional domains are predicted in the ECoV pp1a and pp1ab
and these are summarized in Fig. 1 and Table 2 (Gorbalenya et
al., 1991, 2006; Snijder et al., 2003; Ziebuhr, 2005; Ziebuhr et
al., 2001). Enzymatic activities of nsp3, nsp5, nsp12, nsp13,
nsp14 and nsp15 have been experimentally confirmed for some
coronaviruses (Barretto et al., 2005; Cheng et al., 2005; Guarino
et al., 2005; Heusipp et al., 1997; Ivanov et al., 2004a,b; Ivanov
and Ziebuhr, 2004; Lindner et al., 2005; Minskaia et al., 2006;
Putics et al., 2005, 2006; Seybert et al., 2000, 2005; Tanner et al.,
2003; Ziebuhr, 2005; Ziebuhr et al., 2001). The 3CLpro (catalytic
residues His-3333 and Cys-3437) is predicted to cleave the
C-terminal half of the ECoV pp1a and the ORF1b-encoded part
of pp1ab. The putative PL1pro (catalytic residues Cys-1078 and
His-1229) and PL2pro (catalytic residues Cys-1675 and His-
1832) are predicted to process the N-proximal regions of the
ECoV pp1a (Fig. 1 and Table 2).
The most striking differences between the ECoV replicase
and other group 2 coronaviruses replicases were identified in
nsp3. The ECoV nsp3 protein has 3 aa deletions and 55 aa
insertions compared to the nsp3 proteins of BCoV,HCoV-OC43,
and PHEV, three viruses phylogenetically most closely related to
ECoV. These insertions and deletions are clustered at two
Fig. 1. Schematic diagrams of ECoV genome organization. The ECoV entire genome organization is depicted (middle). The 5′ leader, ORFs 1a and 1b encoding
replicase polyproteins are shown, with the ribosomal frameshift site indicated. Structural and accessory proteins are also indicated: NS2 protein (encoded by ORF2),
hemagglutinin esterase (HE, ORF3), spike protein (S, ORF4), p4.7 protein (ORF5), p12.7 protein (ORF6), envelope protein (E, ORF7), membrane protein (M, ORF8),
nucleocapsid protein (N, ORF9a), and I protein (ORF9b). Predicted cleavage products (nsp1–nsp16) of the replicase polyproteins are depicted (Bottom). Arrows
represent sites in the corresponding replicase polyproteins that are cleaved by papain-like proteases (white arrows) or the 3C-like cysteine protease (black arrows). A
number of putative functional domains predicted in the ECoV pp1a and pp1ab are indicated. PL1, papain-like proteinase 1 (aa 1059–1275); PL2, papain-like
proteinase 2 (aa 1570–1867); X, X-domain which contains adenosine diphosphate-ribose 1ʺ-phosphatase (ADRP) (aa 1276–1435); TM, transmembrane domain;
3CL, 3C-like proteinase; RdRp, RNA-dependent RNA polymerase; Z, zinc-binding domain; HEL, helicase domain; ExoN, exonuclease; N, nidoviral uridylate-
specific endoribonuclease (NendoU); MT, 2′-O-ribose methyltransferase (2′-O-MT). Domains Ac (aa 846–1058) and Y (aa 2310–2796) are described by Ziebuhr et
al. (2001). The spike protein (1363 amino acids) of ECoV is represented by a black line (Top). The N-terminal signal peptide (amino acid residues 1–14 or 17), the
heptad repeat 1 (HR1, amino acid residues 991–1902), the heptad repeat 2 (HR2, amino acid residues 1259–1304), the transmembrane domain (amino acid residues
1308–1330), and the cytoplasmic domain (amino acid residues 1331–1363) are depicted. A potential cleavage recognition sequence (RRQRR) at residues 764–768
and the predicted cleavage site between residues 768 and 769 are indicated. The generated cleavage products S1 and S2 subunits are depicted. The positions of the
receptor-binding domain on the S1 subunit and the fusion peptide on the S2 subunit are currently unknown.
94 J. Zhang et al. / Virology 369 (2007) 92–104regions: the Ac domain and the region between the PL2pro and
the Y domain. The functional significance of these insertions and
deletions is unknown as yet; however, the functions of PL1pro,
PL2pro, and ADRP are not anticipated to be affected sinceTable 1
Coding potential of the ECoV-NC99 genome sequence
ORF Encoded
protein
Nucleotide position
in the genome
5′ Leader 1–64
5′ UTR 1–209
ORF1a pp1a 210–13,499
ORF1a/b pp1ab 210–21,595
ORF2 NS2 21,610–22,446
ORF3 HE 22,458–23,729
ORF4 S 23,744–27,835
ORF5 p4.7 27,825–27,947
ORF6 p12.7 28,076–28,405
ORF7 E 28,392–28,646
ORF8 M 28,661–29,353
ORF9a N 29,363–30,703
ORF9b I 29,424–30,044
3′ UTR 30,704–30,992
a The mRNA used for expression of each protein is derived from the Northern blot
for details.insertions and deletions are not located in the functional domains
of these enzymes (Fig. 1).
ORF2 (nt 21,610–22,446) of ECoV-NC99 encodes the
predicted NS2 protein with 278 amino acids. The NS2 ofNo. of
nucleotides
No. of amino
acids (aa)
mRNA used
for expressiona
64
209
13,290 4429 1
21,386 7128 1
837 278 2
1272 423 3
4092 1363 4
123 40 5
330 109 6
255 84 7
693 230 8
1341 446 9
621 206 9
289
ting analysis and the comparison with other group 2a coronaviruses. See the text
Table 2
Predicted end-products of proteolytic processing of the ECoV replicase polyproteins pp1a and pp1ab
Cleavage
product
Nucleotide
positiona
Polyprotein Position in
pp1a/pp1ab (aa)
Length
(aa)
Putative funcitional
domain(s)b
Putative proteases predicted
to release protein from
polyproteins
nsp1 210–941 pp1a/pp1ab 1Met-Gly244 244 PL1pro
nsp2 942–2744 pp1a/pp1ab 245Val-Ala845 601 PL1pro
nsp3 2745–8597 pp1a/pp1ab 846Gly-Gly2796 1951 Ac, PL1pro, ADRP, PL2pro,
TM1, Y
PL2pro
nsp4 8598–10,085 pp1a/pp1ab 2797Ala-Gln3292 496 TM2 PL2pro+3CLpro
nsp5 10,086–10,994 pp1a/pp1ab 3293Ser-Gln3595 303 3CLpro 3CLpro
nsp6 10,995–11,855 pp1a/pp1ab 3596Ser-Gln3882 287 TM3 3CLpro
nsp7 11,856–12,122 pp1a/pp1ab 3883Ser-Gln3971 89 Part of RNA binding
hexadecameric supercomplex
3CLpro
nsp8 12,123–12,713 pp1a/pp1ab 3972Ala-Gln4168 197 Part of RNA binding
hexadecameric supercomplex
3CLpro
nsp9 12,714–13,043 pp1a/pp1ab 4169Asn-Gln4278 110 ssRNA-binding protein 3CLpro
nsp10 13,044–13,454 pp1a/pp1ab 4279Ala-Gln4415 137 2 zinc fingers 3CLpro
nsp11 13,455–13,496 pp1a 4416Ser-Ser4429 14 3CLpro
nsp12 13,455–16,237 pp1ab 4416Ser-Gln5343 928 RdRp 3CLpro
nsp13 16,238–18,034 pp1ab 5344Ser-Gln5942 599 ZBD, HEL 3CLpro
nsp14 18,035–19,597 pp1ab 5943Cys-Gln6463 521 Exonuclease (ExoN) 3CLpro
nsp15 19,598–20,695 pp1ab 6464Ser-Gln6829 366 NendoU 3CLpro
nsp16 20,696–21,592 pp1ab 6830Ala-Ile7128 299 2′-O-MT 3CLpro
Domains Ac and Y are described by Ziebuhr et al. (2001).
a Nucleotide position means the location of the nucleotides encoding corresponding proteins in the entire genome of equine coronavirus-NC99 strain.
b PL1pro, papain-like proteinase 1; PL2pro, papain-like proteinase 2; ADRP, adenosine diphosphate-ribose 1ʺ-phosphatase (formerly known as ‘X-domain’);
3CLpro, 3C-like proteinase; TM, transmembrane domain; GFL, growth factor-like domain; RdRp, RNA-dependent RNA polymerase; ZBD, zinc-binding domain;
HEL, helicase domain; NendoU, nidoviral uridylate-specific endoribonuclease; 2′-O-MT, 2′-O-ribose methyltransferase.
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respective NS2 proteins of BCoV, HCoV-OC43, and PHEV. The
lower amino acid identity with PHEV may be attributable to the
fact that PHEV has a truncated NS2 protein (Vijgen et al., 2006).
Sequence analysis revealed that the ECoV NS2 protein contains
a domain (aa 46–135) with similarity to the putative cyclic
phosphodiesterase (CPD, Martzen et al., 1999). The CPD
domain has also been identified in the NS2 proteins of other
group 2a coronaviruses as well as in the 3′end of the pp1a protein
of toroviruses (Gorbalenya et al., 2006; Snijder et al., 1991,
2003). The NS2 of ECoV was predicted to contain 9 potential
phosphorylation sites. The NS2 of ECoV does not contain a
signal peptide and is a non-secretory protein. The function of the
NS2 protein in coronaviruses has not been studied in detail. It is
known that theNS2 gene is non-essential for MHVreplication in
transformed cells (Schwarz et al., 1990). However, a recent
study showed that a point mutation in the NS2 of MHV led to its
attenuation in mice in spite of its wild-type replication in tissue
culture (Sperry et al., 2005).
ORF3 (nt 22,458–23,729) of ECoV-NC99 encodes the
predicted HE protein containing 423 amino acids. Nine potential
N-glycosylation sites were predicted. SignalP analysis revealed
a signal peptide probability of 0.802 with a potential cleavage
site between residues 17 and 18. It was predicted that the
N-terminal 390 amino acids are located outside the cell surface
or viral envelope with a transmembrane helix at amino acids
391–413 and an internal domain at amino acids 414–423. The
putative active site for esterase activity, FGDS (Kienzle et al.,
1990), is present at amino acids 36–39 of the HE protein in
ECoV.ORF4 (nt 23,744–27,835) of ECoV-NC99 encodes the
predicted spike (S) protein containing 1363 amino acids. Eighteen
potential N-glycosylation sites were predicted. An N-terminal
signal peptide was identified with a potential cleavage site
between amino acids 14 and 15 predicted by SignalP-NN or
between amino acids 17 and 18 predicted by SignalP-HMM.
The ECoV S protein was predicted to be a typical type I
membrane protein with the N-terminal 1307 residues exposed
on the outside of the cell surface or virus particle, a
transmembrane domain near the C terminus (residues 1308–
1330), followed by a cytoplasmic tail (residues 1331–1363).
Following multiple alignments with the S proteins of other
group 2a coronaviruses, a potential cleavage recognition
sequence (RRQRR) was identified at residues 764–768 which
would predict a cleavage between amino acids 768 and 769,
separating the ECoV S protein into S1 and S2 subunits (Fig. 1).
The ECoV S1 subunit is expected to contain a receptor-binding
domain whose position has not yet been determined. The S2
subunit is predicted to mediate membrane fusion. Two heptad
repeat (HR) regions, which are conserved in position and
sequence among the three groups of coronaviruses and play
important roles in membrane fusion (see reviews of Eckert and
Kim, 2001; Hernandez et al., 1996), were identified in the ECoV
S2 subunit (HR1: aa 991–1092; HR2: aa 1259–1304) (Fig. 1).
The ECoV S2 subunit is anticipated to possess a fusion peptide
whose position is yet unknown. Some coronavirus S proteins
have been shown to contain important neutralization epitopes
(Godet et al., 1994; Kubo et al., 1994; Yoo et al., 1991) and
mutations in the S protein have been associated with altered viral
antigenicity and pathogenicity (Ballesteros et al., 1997; Bernard
Fig. 2. Northern blot analysis of intracellular RNA isolated from ECoV-infected
HRT-18G cells. A DIG-labeled probe which was complementary to the 3′ end
(nt 30,660–30,946) of ECoV genome was used to detect the genomic and
subgenomic mRNAs in ECoV-infected (lane 2) and mock-infected (lane 1)
HRT-18G cells at 72 h p.i.
96 J. Zhang et al. / Virology 369 (2007) 92–104and Laude, 1995; Dalziel et al., 1986; Gallagher and Buchmeier,
2001; Leparc-Goffart et al., 1997). Whether the S protein of
ECoV has such properties remains to be determined.
ORF5 (nt 27,825–27,947) of ECoV-NC99 is predicted to
encode a hypothetical protein of 40 amino acids with an
estimated molecular weight of 4.7 kDa (termed p4.7 protein). It
was predicted to be a non-secretory protein and did not contain
any transmembrane helix. This protein is not closely matched to
any known protein based on a search using BLASTP, PSI-
BLAST, or FASTA programs.Table 3
Oligonucleotide primers used for RT–PCR amplification of the leader–body junctio
Primer ID Position Sequence (5′–3′)
22813N 22,792–22,813 GCGTTATCACCAGAAGCGGT
25095N 25,076–25,095 CGCCTATTCCAGGCAGAAGG
29101N 29,078–29,101 GGCAGTAAGAGTATGATGGT
30945N 30,921–30,945 CTGGGTGGTAACTTAACATG
1P 1–21 GATTGTGAGCGAATTGCGTG
21982N 21,958–21,982 GACGGGACTGACCAACTACA
24283N 24,262–24,283 GCGTGGTGACCCAATACCAC
28100N 28,078–28,100 TCCTCTCAGGTCTCCAGATG
28334N 28,312–28,334 CAGCCTCCTCTATAGTATTGG
28641N 28,617–28,641 CGTCATCCACATTAAGGACT
29016N 28,992–29,016 GGGTTGAAACTCCACCAACT
29710N 29,691–29,710 GCGTTGATTGCCATCGGCTGORF6 (nt 28,076–28,405) of ECoV-NC99 is predicted to
encode a protein of 109 amino acids corresponding to the BCoV
12.7 kDa non-structural protein (p12.7). This ORF overlaps by
15 nucleotides with the ORF7 that encodes the E protein. No
signal peptide or any transmembrane helix was present. No
N-glycosylation site was found.
ORF7 (nt 28,392–28,646) of ECoV-NC99 encodes the pre-
dicted E protein containing 84 amino acids. No N-glycosylation
site was identified. It was predicted to contain a signal anchor
(probability 0.999). One transmembrane domain was predicted
at residues 18–36 by TMpred analysis or at residues 15–37 by
TMHMM analysis. Both programs predicted the N-terminus of
the protein to be external to the cell surface or viral envelope. In
the case of other coronaviruses, there is increasing evidence
that the E protein together with the M protein is instrumental in
viral assembly and budding; the cytoplasmic tails of both
proteins have an important interactive role in this process
(Corse and Machamer, 2000, 2002, 2003; Vennema et al.,
1996).
ORF8 (nt 28,661–29,353) of ECoV-NC99 encodes the
predicted M protein containing 230 amino acids. It was
predicted to contain a signal anchor (probability 0.947). Three
transmembrane domains were predicted to be present at
positions 25–46, 57–78, and 81–102 by TMpred analysis or
at positions 25–44, 49–71, and 81–103 by TMHMM analysis.
The N-terminal 24 amino acid residues were predicted to be
outside and the C-terminal 127 or 128-amino acid hydrophilic
domain was predicted to be inside the virus. One potential N-
glycosylation site was predicted at position 26 (NFS). The
presence of potential O-glycosylation sites was predicted at the
extreme N-terminus of the M protein (MSSTPTPAPGYT).
Whether these sites are glycosylated or not needs to be ex-
perimentally verified. Previous studies have shown that the M
protein of group 1 and 3 coronaviruses (e.g. TGEVand IBV) are
N-glycosylated, whereas the M protein of group 2 coronavirus
MHV is only O-glycosylated (de Haan et al., 2002; Lai et al.,
2006). The M protein is the most abundant envelope component
and plays a key role in coronavirus assembly by interacting with
the E, S, N and HE proteins (Bosch et al., 2005; de Haan and
Rottier, 2005, and references therein).n of sg mRNAs
Use
GC Reverse transcription for mRNA2 (NS2) and reverse
primer for mRNA3 (HE) PCR
Reverse transcription for mRNA3 (HE) and mRNA4 (S)
CCTC Reverse transcription for mRNA5 (p4.7),
mRNA6 (p12.7) and mRNA7 (E)
CTGGC Reverse transcription for mRNA8 (M) and mRNA9 (N)
C Forward primer for all sg mRNA PCR
CAACC Reverse primer for mRNA2 (NS2) PCR
TG Reverse primer for mRNA4 (S) PCR
TCC Reverse primer for mRNA5 (p4.7) PCR
CG Reverse primer for mRNA6 (p12.7) PCR
GGTGG Reverse primer for mRNA7 (E) PCR
ACCAG Reverse primer for mRNA8 (M) PCR
Reverse primer for mRNA9 (N) PCR
Fig. 3. ECoV sg mRNA leader–body junction and flanking sequences. The sg mRNA sequences are shown in alignment with the leader and the genome sequences.
The genomic positions of the nucleotides in the leader and genome sequences are indicated. The start codon AUG in each sg mRNA is depicted in bold. Boxed regions
are the putative TRS used for each sg mRNA synthesis. The 36N and 112N in the parenthesis mean that 36 and 112 nucleotides at that region are not shown.
Homologous nucleotides between the leader and the mRNA or between the mRNA and the genome are indicated with connecting lines.
97J. Zhang et al. / Virology 369 (2007) 92–104ORF9a (nt 29,363–30,703) of ECoV-NC99 encodes the
predicted N protein containing 446 amino acids. It was predicted
to contain 36 potential phosphorylation sites. No signal peptide
or any transmembrane helix was present. The N protein of
coronaviruses has been shown to be multifunctional, e.g.
interaction with the viral RNA genome to form a viral nucleo-
capsid, interaction with the M protein, and the ability for self-
association (Masters, 1992; Narayanan et al., 2000, 2003).
Recently it has also been reported that the N protein may play a
role in coronavirus replication (Almazan et al., 2004; Schelle
et al., 2005).
ORF9b (nt 29,424–30,044) of ECoV-NC99 encodes a
hypothetical protein (I) containing 206 amino acids within
ORF9a which encodes the N protein. It was predicted to contain10 potential phosphorylation sites. No signal peptide or any
transmembrane helix was present. In the case of MHV,
expression of the protein I has been detected in virus-infected
cells but this protein is nonessential for viral replication and viral
production (Fischer et al., 1997).
Northern blot analysis of ECoV genomic and subgenomic
mRNAs
It is generally accepted that the replicase proteins are directly
synthesized from the coronavirus genome, whereas the
structural and accessory proteins are expressed from a nested
set of subgenomic mRNAs. However, the number of sg
mRNAs and the characteristics and expression pattern of the
98 J. Zhang et al. / Virology 369 (2007) 92–104
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multiple proteins) varies for each virus. In order to investigate
ECoV sg mRNA synthesis, Northern blot analysis was
performed to evaluate the synthesis of genomic and sub-
genomic RNAs in ECoV-infected cells. A digoxigenin-labeled
RNA probe complementary to the 3′ end (nt 30,660–30,946) of
the ECoV genome was used for a Northern blot hybridization
analysis. As shown in Fig. 2, nine mRNAs were detected in
ECoV-infected HRT-18G cells at 72 h p.i. Absence of such
mRNAs in mock-infected cells confirms that these mRNAs are
ECoV-specific. According to the estimated sizes of the mRNAs,
it is reasonable to assume that sg mRNAs 2–8 express the NS2,
HE, S, p4.7, p12.7, E, and M proteins, respectively and that
mRNA 9 expresses the N protein and probably the I protein as
well.
Determination of leader–body junction sequences of sg mRNAs
There is a general agreement that the TRS elements
determine the fusion sites of the 5′ leader and the 3′ body
segments in coronavirus sg mRNAs. In order to determine the
precise location of the leader and body TRSs used for ECoV sg
mRNA synthesis, the leader–body junction and flanking
sequences of each ECoV sg mRNA were determined using
sg mRNA-specific RT–PCRs (see Table 3 and Materials and
methods for details). The sg mRNA sequences were aligned to
the leader and corresponding ‘body’ genomes as shown in Fig.
3. Analysis of the leader–body junction sequences revealed
that the core sequence of the TRS motifs is 5′UCUAAAC3′.
The leader TRS (5′UCUAAAC3′) and the body TRS (5′
UCUAAAC3′) used for synthesizing HE mRNA, S mRNA,
and N mRNA exactly match each other. There is one mismatch
between the leader TRS and the body TRS (5′UCUAAAA3′)
used for generating the mRNA of the NS2 protein. There is
also one mismatch between the leader TRS and the body TRS
(5′UCCAAAC3′) used for generating E mRNA and M
mRNA. There are two mismatches between the leader TRS
and the body TRS (5′UUAAAAC3′) used for generating the
mRNA of the p4.7 protein. Interestingly, in the case of the
mRNA of the p12.7 protein, the leader and the body segment
is joined at the unusual consensus variant 5′UAAA-
CUUUAUAA3′. Previously it has been shown that the
mRNA of the p12.7 protein of BCoV also utilizes an unusual
consensus variant for joining the leader and body segment
(Hofmann et al., 1993). From the sequence data, we conclude
that the ECoV common leader on sg mRNAs is the first 64
nucleotides of the ECoV genome.Fig. 4. Phylogenetic analysis of the amino acid sequences of replicase polyprotein pp1
and nucleocapsid (N) of ECoV-NC99. Multiple amino acid sequence alignments were
constructed using PAUP 4.0b10. Bootstrap analysis was carried out on 1000 replica
TGEV, porcine transmissible gastroenteritis virus Purdue (NC_002306); FCoV,
(NC_005831); HCoV-229E, human coronavirus 229E (NC_002645); PEDV, porcine
(NC_003045); HCoV-OC43, human coronavirus OC43 strain VR759 (NC_005147);
MHV, murine hepatitis viruses A59 (NC_001846) and JHM (NC_006852); SDAV, rat
(NC_006577); SARS-CoV, SARS coronavirus Tor2 (NC_004718); IBV, avian infecPhylogenetic analysis of ECoV
Phylogenetic analyses of ECoVand other coronaviruses were
performed based on the amino acid sequences of replicase
polyprotein pp1a, the ORF1b-encoded part of the pp1ab, S, E,
M, and N. Phylogenetic analysis clustered coronaviruses into
three major groups (G1, G2a, and G3) irrespective of the gene
used for analysis (Fig. 4). The SARS-CoV forms a separate
branch and is classified as subgroup 2b (G2b) as suggested
previously (Gorbalenya et al., 2004; Snijder et al., 2003).
Phylogenetic analysis clearly demonstrated that ECoV falls into
the cluster of group 2a coronaviruses and is most closely related
to BCoV, HCoV-OC43, and PHEV.
To further explore the possible evolutionary relationships
among ECoV, BCoV, HCoV-OC43, and PHEV, the genetic
distances of ECoV, BCoV, and PHEV to HCoV-OC43 were
determined over the entire genome using the SimPlot analysis
(Lole et al., 1999). As shown in Fig. 5, the BCoV strains and
HCoV-OC43 had lowest genetic distances over the complete
genome; the genetic distance between PHEV and HCoV-OC43
was similar to the distance between BCoV and HCoV-OC43 in
most regions of the genome with exception of the spike gene
where the genetic distance of PHEV to HCoV-OC43 was
significantly greater than the distance of BCoV to HCoV-
OC43; the genetic distance of ECoV to HCoV-OC43 was
significantly greater than the distance of either BCoVor PHEV
to HCoV-OC43 in the regions of the first half of ORF1a, the
central part of ORF1b, NS2 and HE genes; the genetic
distance with respect to the spike gene between ECoV and
HCoV-OC43 was similar to the distance between PHEV and
HCoV-OC43 but greatly higher than the distance between
BCoV and HCoV-OC43. The genetic distances of BCoV and
PHEV to HCoV-OC43 observed in this study are consistent
with previously reported findings (Vijgen et al., 2005, 2006).
Vijgen et al. (2006, 2005) concluded that PHEV diverged from
the common ancestor before BCoV and HCoV-OC43. Our
analysis suggested that ECoV had diverged earlier than PHEV
from a common ancestor. In summary, ECoV had emerged
earlier than PHEV, BCoV, and HCoV-OC43, notwithstanding
the fact that ECoV was not isolated until 1999 from a diarrheic
foal in USA.
Conclusion
In this study, we have determined the first complete genome
sequence of ECoVand provided the first comprehensive analysis
of the ECoV genome. Completion of the genome sequence ofa, the ORF1b-encoded part of the pp1ab, spike (S), envelope (E), membrane (M),
carried out by using ClustalX 1.83 and the unrooted neighbor-joining trees were
te data sets. CCoV, canine coronavirus (GenBank accession number D13096);
feline coronavirus (NC_007025); HCoV-NL63, human coronavirus NL63
epidemic diarrhea virus CV777 (NC_003436); BCoV, bovine coronavirus ENT
PHEV, porcine hemagglutinating encephalomyelitis virus VW572 (DQ011855);
sialodacryoadenitis coronavirus (AF207551); HCoV-HKU1, coronavirus HKU1
tious bronchitis virus Beaudette (NC_001451).
Fig. 5. Genetic distance between ECoV, BCoV, PHEV and HCoV-OC43. The average genetic distances were calculated over the entire genome using the SimPlot
program with a sliding window size of 400 bp and a step size of 200 bp. Each curve represents a comparison of the sequence data of ECoV-NC99, the BCoV strains,
and PHEV-VW572 to the reference sequence data of the HCoV-OC43 ATCC strain VR759 (NC_005147). The sequence data of the BCoV strains used for comparison
are the 50% consensus sequence of six BCoV strains: BCoV-ENT (NC_003045), BCoV-Alpaca (DQ915164), BCoV-DB2 (DQ811784), BCoV-Mebus (U00735),
BCoV-Quebec (AF220295), and BCoV-LUN (AF391542). The linear representation of the ECoV-NC99 genome was shown at the top of the diagram.
100 J. Zhang et al. / Virology 369 (2007) 92–104ECoV will contribute to our understanding of this virus at the
molecular level and also enrich the database of coronaviruses.
The sequence data are expected to aid in the development of
diagnostic and prophylactic reagents. The sequence data of
ECoV-NC99will also help identify and characterize other ECoV
isolates and enhance our understanding of the molecular
epidemiology of coronavirus. Neonatal enterocolitis is an
economically significant disease for horse breeders. Further
studies are needed to determine the prevalence of ECoV in-
fection in equine populations and the relative role of ECoVas a
cause of enteric disease in horses.
Materials and methods
Cells and virus
The human rectal tumor cell line HRT-18G (American
Type Culture Collection [ATCC, CRL-11663]) was grown in
Dulbecco's modified Eagle's medium (DMEM) supplemented
with 4 mM L-glutamine, 5% fetal bovine serum, and
penicillin/streptomycin at 37 °C in the presence of 5% CO2.
The equine coronavirus-NC99 (Guy et al., 2000) was
propagated once in HRT-18G cells to produce the working
virus stocks.Isolation of viral RNA, RT–PCR amplification and sequencing
The complete genome of ECoV was determined by sequencing
11 overlapping RT–PCR products encompassing the entire
genome (nt 1–3615; nt 3446–5458; nt 4953–6600; nt 5497–
9678; nt 9347–13,021; nt 12,451–15,736; nt 15,425–19,307; nt
19,039–22,812; nt 22,566–26,390; nt 26,065–29,662; and nt
29,363–30,992). Viral RNAwas isolated from ECoV stocks using
the QIAamp viral RNA mini kit (Qiagen). Viral RNA was first
reverse transcribed with AccuScript reverse transcriptase (Strata-
gene) following the manufacturer's instructions. Then, PCR
amplification was performed with proof-reading PfuUltra high-
fidelity DNA polymerase (Stratagene) in a volume of 50 μl: 5 μl
PfuUltra PCR buffer (10×), 1.0μl dNTPmix (10mMeach), 1μl of
each primer (20 μM), 2 μl cDNA template, 1 μl PfuUltra DNA
polymerase, and 39.0 μl nuclease-free water. The reaction mixtures
were incubated at 95 °C for 2 min, followed by 35 cycles of
amplification at 95 °C for 45 s, 50–53 °C for 45 s, and 72 °C for
4.5 min, with a final incubation at 72 °C for 10 min. The PCR
products were gel-purified using QIAquick gel extraction kit
(Qiagen). Both sense and anti-sense strands were sequenced using
the Applied Biosystems Big Dye Terminator V3.0 sequencing
chemistry on ABI 3730 DNA sequencers (Davis Sequencing
Center). Partial genomic sequence (9487 nucleotides) of ECoV had
101J. Zhang et al. / Virology 369 (2007) 92–104been previously determined by two groups (Guy et al., 2000,
GenBank accession number AF251144; Wu et al., 2003,
AF523846 and AF523850. H.Y. Wu, J.S. Guy, and D.A. Brian,
unpublished data, AY316300). These regions were re-sequenced in
this study. To determine the remaining genomic sequence of ECoV-
NC99, initial RT–PCR and sequencing primers were designed
based on multiple alignments of the genomes of BCoV (GenBank
accession number NC_003045), HCoV-OC43 (NC_005147),
PHEV (DQ011855), and MHV (NC_001846); additional primers
were designed based on the results of the first and subsequent
rounds of sequencing. All of the primer sequences are attached in
the Supplementary Table S1.
DNA and protein sequence analysis
The nucleotide sequences were assembled and manually
edited using CodonCode Aligner version 1.5.2 to produce the
complete sequence of the viral genome. ORF analysis was
performed using Vector NTI Advance 10 (Invitrogen). RNA
secondary structures of 5′ and 3′ UTRs and the ribosomal
frameshift signals were predicted using the MFOLD program
with the default parameter settings (Mathews et al., 1999; Zuker,
2003). Potential 3C-like protease cleavage sites were predicted
using the NetCorona 1.0 server (Kiemer et al., 2004). Prediction
of signal peptides and their cleavage sites was conducted using
SignalP 3.0 server (Nielsen et al., 1997). Potential N-glycosyla-
tion sites, O-glycosylation sites, and phosphorylation sites were
predicted using NetNGlyc, NetOGlyc, and NetPhos, respec-
tively (Blom et al., 1999; Julenius et al., 2005). Prediction of
transmembrane domains was performed using TMpred (Hof-
mann and Stoffel, 1993) and TMHMM server 2.0 (Sonnhammer
et al., 1998). Protein similarity searches were performed using
BLASTP version 2.2.16, PSI-BLAST against the Protein Data
Bank (PDB) (Altschul et al., 1997; Schaffer et al., 2001) and
FASTA version 34.26 against the uniprot protein database with
the default parameter settings (Pearson and Lipman, 1988).
Pairwise amino acid comparison was performed using EMBOSS
Pairwise Alignment Algorithms with the default parameter
settings (http://www.ebi.ac.uk/emboss/align). Multiple se-
quence alignments were performed using ClustalX version
1.83 (Thompson et al., 1997). Phylogenetic analysis and
unrooted neighbor-joining trees were carried out using PAUP
version 4.0b10 with the default parameter settings. Bootstrap
analysis was carried out on 1000 replicate data sets. The genetic
distance between genomes was determined using the SimPlot
version 3.5.1 (Lole et al., 1999).
Analysis of viral RNA by Northern blotting
One anti-sense RNA probe base pairing to the 3′ end of the
ECoV genome (nt 30,660–30,946) was developed to evaluate
the synthesis of genomic and subgenomic RNAs in ECoV-
infected cells by Northern blotting. The ECoV RNA was
amplified using two primer pairs (forward primer 30660P: 5′
AGCAGATGGATGATCCCCTC3′; reverse primer 30946N: 5′
ACTGGGTGGTAACTTAACATGCTG3′) and the QIAgen
One-step RT–PCR kit (Qiagen). The gel-purified RT–PCRproducts were cloned into a linearized plasmid vector with
overhanging 3′ T residues (pDrive Cloning Vector, Qiagen). The
authenticity and orientation of the insert was determined by
sequencing both strands of DNAwith M13 reverse and forward
primers. Plasmid DNA was linearized with BamHI (Roche),
phenol/chloroform extracted, ethanol precipitated, and resus-
pended in nuclease-free water. A digoxigenin (DIG)-labeled
RNA probe was prepared using the DIG RNA labeling kit
(Roche) according to the manufacturer's instructions.
Intracellular RNA was extracted at 72 h p.i. from ECoV-
infected HRT-18G cells using the RNAqueous-4PCR kit
(Ambion). Northern hybridization with the DIG-labeled RNA
probe was carried out following the protocols that had been
previously described for equine arteritis virus (Balasuriya et al.,
2004).
Determination of the leader–body junction sequence
The leader–body junction sites of all ECoV sg mRNAs were
RT–PCR amplified and sequenced. Briefly, intracellular RNAwas
extracted from ECoV-infected HRT-18G cells using the RNAqu-
eous-4PCR kit (Ambion). Reverse transcription was carried out
with an RT primer located downstream to the body TRS region in a
sg mRNA (Table 3) using SuperscriptIII reverse transcriptase
(Invitrogen) following the manufacturer's instructions. Due to the
nested nature of sg mRNAs, such an RT primer also binds to the
corresponding positions in all larger viral mRNAs, including the
genomic RNA. Subsequently, cDNA was PCR amplified with a
forward primer (1P) located in the leader sequence and a reverse
primer located just upstream of the RT primer in the body of the
mRNA (Table 3). Amplification was performed in a volume of
50 μl: 5 μl PfuTurbo PCR buffer (10×), 0.4 μl dNTP mix (25 mM
each), 1 μl of each primer (20 μM), 2 μl cDNA template, 1 μl
PfuTurbo®DNA polymerase, and 39.6 μl nuclease-free water. The
reaction mixtures were incubated at 95 °C for 2 min, followed by
35 cycles at 95 °C for 45 s, 50–56 °C for 45 s, and 72 °C for 3 min,
with a final incubation at 72 °C for 10 min. RT–PCR products
corresponding to each mRNA species could be distinguished by
size differences on agarose gel. PCRproductswere gel-purified and
sequenced to obtain the leader–body junction sequences for each sg
mRNA.
Nucleotide sequence accession number
The nucleotide sequence of ECoVwas deposited in GenBank
under the accession number EF446615.
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